
IN BRIEF: Poolbeg Pharma shares rise as first human trial begins
Poolbeg Pharma PLC - London-based pharmaceutical company - Receives approval to commence its Lipopolysaccharide human clinical trial for POLB 011, a drug that aims to treat severe influenza. The trial...
Read more